Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Loss of LKB1/ STK11 Facilitates Leukemic Progression of the Myeloproliferative Neoplasms

Christian Marinaccio, MSc, Praveen K Suraneni, PhD, Hamza Celik, PhD, Andrew Volk, PhD, Jeremy Q. Wen, MD PhD, Te Ling, PhD, Terra Lasho, PhD, Richard P. Koche, PhD, Christopher Famulare, MS, Brady L. Stein, MD, Sandeep Gurbuxani, MBBS, PhD, Ronald Hoffman, MD, Naseema Gangat, MBBS, Navdeep Chandel, Ross L. Levine, MD, Raajit K. Rampal, MD PhD, Grant Challen, Ayalew Tefferi, MD, John D. Crispino, PhD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-140557

Published: 2020

Journal Articles

To Treat or Not to Treat? Understanding Treatment Patterns in Patients with Lower-Risk Myelofibrosis at the Time of Enrollment in the MOST Study

Rami S. Komrokji, MD, Brady L. Stein, MD MHSc, Robyn M. Scherber, MD, Patricia Kalafut, PhD, Haobo Ren, PhD, Srdan Verstovsek, MD PhD

Blood (2020) 136 (Supplement 1): 49–51.

https://doi.org/10.1182/blood-2020-134958

Published: 2020

Journal Articles

Mortality and Causes of Death of Patients with Polycythemia Vera: Analysis of the Reveal Prospective, Observational Study

Brady L. Stein, MD MHSc, Kamal Patel, MD, Robyn M. Scherber, MD, Jingbo Yu, MD PhD, Dilan Paranagama, PhD, Carole B. Miller, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-137144

Published: 2020

Journal Articles

Long-Term Antithrombotic Therapy after Venous Stent Placement

Chenyu Lin, MD, Karlyn A. Martin, MD, Mei Wang, PhD, Brady L. Stein, MD, Kush R. Desai, MD

Blood (2018) 132 (Supplement 1): 1249.

https://doi.org/10.1182/blood-2018-99-111069

Published: 2018

Journal Articles

Temporary and Permanent Inferior Vena Cava Filters in the Oncology Population

Suneel Deepak Kamath, MD, Elizabeth H. Cull, MD, Brady L. Stein, MD, Robert Lewandowski, MD, Brandon McMahon, MD

Blood (2016) 128 (22): 1423.

https://doi.org/10.1182/blood.V128.22.1423.1423

Published: 2016

Journal Articles

Examining the Clinical Features and Underlying Cardiovascular Risk Among Patients with Polycythemia Vera in the REVEAL Study

Brady L. Stein, MD, Ahmad Naim, MD, Michael R. Grunwald, MD, Alison R. Moliterno, MD, Stephen T. Oh, MD PhD, Dilan Paranagama, PhD, Joseph A. Cordaro, PharmD, MBA, Hao Sun, MS, Shreekant Parasuraman, BPharm, PhD, Ralph V. Boccia, Ruben Mesa, MD FACP

Blood (2016) 128 (22): 1934.

https://doi.org/10.1182/blood.V128.22.1934.1934

Published: 2016

Journal Articles

Defect in Ribosome Biogenesis Contributes to Impaired Megakaryopoiesis in Primary Myelofibrosis

Laure Gilles, PhD, Ahmet Dirim Arslan, PhD, Katerina Konstantinoff, Maureen McNulty, Lasho Terra, PhD, Animesh Pardanani, MBBS, PhD, Brady L Stein, MD, Isabelle Plo, William Vainchenker, MD PhD, Leonidas Platanias, Ayalew Tefferi, MD, John D Crispino, PhD

Blood (2014) 124 (21): 4585.

https://doi.org/10.1182/blood.V124.21.4585.4585

Published: 2014

Journal Articles

Temporary Vena Cava Filters in Oncology Patients

Elizabeth H Cull, MD, Robert Lewandowski, MD, Brady L Stein, MD, Brandon McMahon, MD

Blood (2014) 124 (21): 4247.

https://doi.org/10.1182/blood.V124.21.4247.4247

Published: 2014

Journal Articles

A Phase 1/2, Open-Label, Dose-Escalation, Multi-Center Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered NS-018 in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (postPV MF), or Post-Essential Thrombocythemia Myelofibrosis (postET MF)

Srdan Verstovsek, MD PhD, Moshe Talpaz, MD, Ellen K. Ritchie, MD, Martha Wadleigh, MD, Olatoyosi Odenike, MD, Catriona Jamieson, MD PhD, Brady L Stein, MD, Uno Tomonori, PhD, Ruben Mesa, MD

Blood (2014) 124 (21): 1839.

https://doi.org/10.1182/blood.V124.21.1839.1839

Published: 2014

Journal Articles

Clinical Use Of Anti-Xa Monitoring In Malignancy-Associated Thrombosis

Brandon McMahon, MD, Sarah Yentz, MD, Oluwatoyosi A. Onwuemene, MD, Brady L. Stein, MD, Elizabeth H. Cull, MD

Blood (2013) 122 (21): 3648.

https://doi.org/10.1182/blood.V122.21.3648.3648

Published: 2013

Journal Articles

Clinical Factors Associated With Bleeding In Ph-Negaitve MPN

Sania S. Raza, MD, Zheng Zhou, MD, PhD, Brady L. Stein, MD

Blood (2013) 122 (21): 3605.

https://doi.org/10.1182/blood.V122.21.3605.3605

Published: 2013

Journal Articles

The Natural History Of Polycythemia Vera In Two Diagnostic Eras

Brady L Stein, MD MHS, Zheng Zhou, MD, PhD, Jerry L. Spivak, MD, Alison R. Moliterno, MD

Blood (2013) 122 (21): 4078.

https://doi.org/10.1182/blood.V122.21.4078.4078

Published: 2013

Journal Articles

Modified Dose Escalation Of Ruxolitinib: A Feasible Therapeutic Approach In The Management Of Myelofibrosis

Ali Tabarroki, MD, Daniel Lindner, Valeria Visconte, PhD, Heesun J. Rogers, MD, PhD, John Desamito, Hien K. Duong, MD, Alan E. Lichtin, Anjali S. Advani, MD, Ronald M. Sobecks, MD, Tracy Cinalli, RN, Kristin Dodd, RN, Jing Ai, MD, PhD, Yogen Saunthararajah, M.D., Matt Kalaycio, MD, Brady L. Stein, MD, Mikkael A. Sekeres, MD, MS, Ramon V. Tiu, MD

Blood (2013) 122 (21): 1586.

https://doi.org/10.1182/blood.V122.21.1586.1586

Published: 2013

Journal Articles

Aurora A Kinase Is a Novel Therapeutic Target In The Myeloproliferative Neoplasms

Qiang Jeremy Wen, PhD, MD, Benjamin Goldenson, Sebastien Malinge, PhD, Brady L Stein, MD MHS, Terra L Lasho, MT, (ASCP), Lawrence Breyfogle, Rachael Schultz, Qiong Yang, Laure gilles-Gendre, Priya Koppikar, Omar Abdel-Wahab, MD, Benjamin L. Ebert, MD, PhD, Animesh Pardanani, MBBS, PhD, Sandeep Gurbuxani, MBBS, PhD, Ross L. Levine, MD, Ann Mullally, MD, Ayalew Tefferi, MD, John D Crispino, PhD

Blood (2013) 122 (21): 109.

https://doi.org/10.1182/blood.V122.21.109.109

Published: 2013

Journal Articles

Polycythemia Vera: Redefinition in the Genomic Era

Alison R. Moliterno, MD, Donna M. Williams, PhD, Michael A McDevitt, MD, PhD, Brady L Stein, MD, Jonathan M. Gerber, MD, Ophelia Rogers, Michael B. Streiff, MD, Sophie Lanzkron, M.D., Linda Resar, M.D., Christine O'Keefe, PhD, Jaroslaw P. Maciejewski, MD, PhD, Jerry L. Spivak, MD

Blood (2012) 120 (21): 1754.

https://doi.org/10.1182/blood.V120.21.1754.1754

Published: 2012

Journal Articles

Tissue-Factor Bearing Microparticles and Thrombotic Risk in the Myeloproliferative Neoplasms

Brady L Stein, MD, Brandon McMahon, MD, Ivy Weiss, BS, Hau C. Kwaan, M.D., Ph.D.

Blood (2012) 120 (21): 1145.

https://doi.org/10.1182/blood.V120.21.1145.1145

Published: 2012

Journal Articles

The Molecular and Cytokine Profile of Triple-Negative ( JAK2 V617F, JAK2 exon 12, MPL negative) Myelofibrosis, a Myeloproliferative Neoplasm with Distinct Clinico-Pathologic Characteristics

Ali Tabarroki, MD, Heesun J. Rogers, MD, PhD, Valeria Visconte, PhD, Edy Hasrouni, Anjali Advani, MD, Mikkael A. Sekeres, MD, MS, Hien K. Duong, MD, Matt Kalaycio, MD, Edward A. Copelan, MD, Brady L Stein, MD, Ramon V. Tiu, MD

Blood (2012) 120 (21): 3805.

https://doi.org/10.1182/blood.V120.21.3805.3805

Published: 2012

Journal Articles

Tissue Factor Bearing Microparticles in the Myeloproliferative Neoplasms

Brady L Stein, MD, Brandon McMahon, MD, Ivy Weiss, BS, James Marvin, MS, Hau C. Kwaan, M.D., Ph.D.

Blood (2011) 118 (21): 5174.

https://doi.org/10.1182/blood.V118.21.5174.5174

Published: 2011

Journal Articles

Age-Related Differences in Disease Characteristics and Clinical Outcomes in Polycythemia Vera

Brady L Stein, MD, Jerry L. Spivak, MD, Alison R. Moliterno, MD

Blood (2011) 118 (21): 1758.

https://doi.org/10.1182/blood.V118.21.1758.1758

Published: 2011

Journal Articles

Disruption of the ASXL1 Gene Is Prevalent In PMF: Analysis of Molecular Genetics and Clinical Phenotypes

Brady L Stein, MD, Donna M Williams, PhD, Michael A McDevitt, MD, PhD, Christine L. O'Keefe, PhD, Ophelia Rogers, Jerry L Spivak, Jaroslaw Maciejewski, Alison R Moliterno, MD

Blood (2010) 116 (21): 3074.

https://doi.org/10.1182/blood.V116.21.3074.3074

Published: 2010

NARROW

Loss of LKB1/ STK11 Facilitates Leukemic Progression of the Myeloproliferative Neoplasms

To Treat or Not to Treat? Understanding Treatment Patterns in Patients with Lower-Risk Myelofibrosis at the Time of Enrollment in the MOST Study

Mortality and Causes of Death of Patients with Polycythemia Vera: Analysis of the Reveal Prospective, Observational Study

Long-Term Antithrombotic Therapy after Venous Stent Placement

Temporary and Permanent Inferior Vena Cava Filters in the Oncology Population

Examining the Clinical Features and Underlying Cardiovascular Risk Among Patients with Polycythemia Vera in the REVEAL Study

Defect in Ribosome Biogenesis Contributes to Impaired Megakaryopoiesis in Primary Myelofibrosis

Temporary Vena Cava Filters in Oncology Patients

Clinical Use Of Anti-Xa Monitoring In Malignancy-Associated Thrombosis

Clinical Factors Associated With Bleeding In Ph-Negaitve MPN

The Natural History Of Polycythemia Vera In Two Diagnostic Eras

Modified Dose Escalation Of Ruxolitinib: A Feasible Therapeutic Approach In The Management Of Myelofibrosis

Aurora A Kinase Is a Novel Therapeutic Target In The Myeloproliferative Neoplasms

Polycythemia Vera: Redefinition in the Genomic Era

Tissue-Factor Bearing Microparticles and Thrombotic Risk in the Myeloproliferative Neoplasms

The Molecular and Cytokine Profile of Triple-Negative ( JAK2 V617F, JAK2 exon 12, MPL negative) Myelofibrosis, a Myeloproliferative Neoplasm with Distinct Clinico-Pathologic Characteristics

Tissue Factor Bearing Microparticles in the Myeloproliferative Neoplasms

Age-Related Differences in Disease Characteristics and Clinical Outcomes in Polycythemia Vera

Disruption of the ASXL1 Gene Is Prevalent In PMF: Analysis of Molecular Genetics and Clinical Phenotypes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only